PROVIDER PROFILE · NPI 1720279425

Betul OranM.D.

MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
132
Unique beneficiaries
—
Total services
491
Distinct HCPCS
4
Medicare payment
$47K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 19 Hematopoietic Cell Transplantation and Cellular Therapy providers in TX — above median (cohort median 519).
PRESCRIBING · PART D · 2024
Total Rx claims
75
Beneficiaries
—
Total drug cost
$11K
Distinct drugs
4
Brand share
38.7%
Top prescribed drugs
QUALITY · MIPS · 2024
Final MIPS score
84.3
Quality
70.8
Cost
67.6
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.39%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

Hospital
REFERRAL NETWORK

Where Betul Oran's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 18 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER712,591
TARRAND, JEFFREY25250
Cheng Yin
Pathology · Houston, TX
1877
Girish Shroff
Diagnostic Radiology · Houston, TX
1894
Jeffrey Jorgensen
Pathology · Houston, TX
17113
Mary Elliott
Physician Assistant · Shenandoah, TX
1691
Pedro Cano
Pathology · Tampa, FL
15101
Kara Thompson
Cardiology · Houston, TX
1592
Rashmi Kanagal Shamanna
Pathology · Houston, TX
1546
Keyur Patel
Pathology · Houston, TX
1485
Juan Lopez-Mattei
Cardiology · Fort Myers, FL
1480
Peter Kim
Cardiology · Houston, TX
14103
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.